Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001641172-25-011470
Filing Date
2025-05-19
Accepted
2025-05-19 16:30:39
Documents
19
Period of Report
2025-05-19

Document Format Files

Seq Description Document Type Size
1 PRE 14A formpre14a.htm   iXBRL PRE 14A 450441
2 GRAPHIC formpre14a_001.jpg GRAPHIC 6927
3 GRAPHIC proxy_001.jpg GRAPHIC 691707
4 GRAPHIC proxy_002.jpg GRAPHIC 491430
  Complete submission text file 0001641172-25-011470.txt   3875674

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE aztr-20241231.xsd EX-101.SCH 3419
6 XBRL DEFINITION FILE aztr-20241231_def.xml EX-101.DEF 5345
7 XBRL LABEL FILE aztr-20241231_lab.xml EX-101.LAB 52575
8 XBRL PRESENTATION FILE aztr-20241231_pre.xml EX-101.PRE 39413
22 EXTRACTED XBRL INSTANCE DOCUMENT formpre14a_htm.xml XML 3774
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41705 | Film No.: 25964464
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)